Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Serological investigation of racehorse vaccination against equine influenza in Morocco.

Dilai M, Piro M, Fougerolle S, El Harrak M, Mahir W, El Mourid R, Legrand L, Paillot R, Fassi Fihri O.

Vet Microbiol. 2018 Sep;223:153-159. doi: 10.1016/j.vetmic.2018.08.014. Epub 2018 Aug 11.

PMID:
30173741
2.

The Immunity Gap Challenge: Protection against a Recent Florida Clade 2 Equine Influenza Strain.

Paillot R, Garrett D, Lopez-Alvarez MR, Birand I, Montesso F, Horspool L.

Vaccines (Basel). 2018 Jul 2;6(3). pii: E38. doi: 10.3390/vaccines6030038.

3.

A comprehensive analysis of e-CAS cell line reveals they are mouse macrophages.

Evans E, Paillot R, López-Álvarez MR.

Sci Rep. 2018 May 29;8(1):8237. doi: 10.1038/s41598-018-26512-3.

4.

Improved de novo genomic assembly for the domestic donkey.

Renaud G, Petersen B, Seguin-Orlando A, Bertelsen MF, Waller A, Newton R, Paillot R, Bryant N, Vaudin M, Librado P, Orlando L.

Sci Adv. 2018 Apr 4;4(4):eaaq0392. doi: 10.1126/sciadv.aaq0392. eCollection 2018 Apr.

5.

Equine Vaccines: How, When and Why? Report of the Vaccinology Session, French Equine Veterinarians Association, 2016, Reims.

Paillot R, Marcillaud Pitel C, D'Ablon X, Pronost S.

Vaccines (Basel). 2017 Dec 4;5(4). pii: E46. doi: 10.3390/vaccines5040046.

6.

Refinement of the equine influenza model in the natural host: A meta-analysis to determine the benefits of individual nebulisation for experimental infection and vaccine evaluation in the face of decreased strain pathogenicity.

Garrett D, Montesso F, Fougerolle S, Lopez-Alvarez MR, Birand I, De Bock M, Huang CM, Legrand L, Pronost S, Paillot R.

Vet Microbiol. 2017 Nov;211:150-159. doi: 10.1016/j.vetmic.2017.10.010. Epub 2017 Oct 10.

PMID:
29102112
7.

Equine PBMC Cytokines Profile after In Vitro α- and γ-EHV Infection: Efficacy of a Parapoxvirus Ovis Based-Immunomodulator Treatment.

Hue ES, Richard EA, Fortier CI, Fortier GD, Paillot R, Raue R, Pronost SL.

Vaccines (Basel). 2017 Sep 19;5(3). pii: E28. doi: 10.3390/vaccines5030028.

8.

Immunogenicity of phospholipase A2 toxins and their role in Streptococcus equi pathogenicity.

López-Álvarez MR, Salze M, Cenier A, Robinson C, Paillot R, Waller AS.

Vet Microbiol. 2017 May;204:15-19. doi: 10.1016/j.vetmic.2017.04.002. Epub 2017 Apr 4.

PMID:
28532794
9.

Genetic evolution of equine influenza virus strains (H3N8) isolated in France from 1967 to 2015 and the implications of several potential pathogenic factors.

Fougerolle S, Legrand L, Lecouturier F, Sailleau C, Paillot R, Hans A, Pronost S.

Virology. 2017 May;505:210-217. doi: 10.1016/j.virol.2017.02.003. Epub 2017 Mar 11.

10.

Strangles: A modern clinical view from the 17th century.

Paillot R, Lopez-Alvarez MR, Newton JR, Waller AS.

Equine Vet J. 2017 Mar;49(2):141-145. doi: 10.1111/evj.12659. No abstract available.

PMID:
28177153
11.

How to Meet the Last OIE Expert Surveillance Panel Recommendations on Equine Influenza (EI) Vaccine Composition: A Review of the Process Required for the Recombinant Canarypox-Based EI Vaccine.

Paillot R, Rash NL, Garrett D, Prowse-Davis L, Montesso F, Cullinane A, Lemaitre L, Thibault JC, Wittreck S, Dancer A.

Pathogens. 2016 Nov 25;5(4). pii: E64. Review.

12.

The Use of a Recombinant Canarypox-Based Equine Influenza Vaccine during the 2007 Australian Outbreak: A Systematic Review and Summary.

Paillot R, El-Hage CM.

Pathogens. 2016 Jun 10;5(2). pii: E42. doi: 10.3390/pathogens5020042. Review.

13.

Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals.

Fougerolle S, Legrand L, Garrett D, Birand I, Foursin M, D'Ablon X, Bayssat P, Newton RJ, Pronost S, Paillot R.

Vaccine. 2016 Jul 19;34(33):3787-95. doi: 10.1016/j.vaccine.2016.05.068. Epub 2016 Jun 10.

PMID:
27269055
14.

Genome specialization and decay of the strangles pathogen, Streptococcus equi, is driven by persistent infection.

Harris SR, Robinson C, Steward KF, Webb KS, Paillot R, Parkhill J, Holden MT, Waller AS.

Genome Res. 2015 Sep;25(9):1360-71. doi: 10.1101/gr.189803.115. Epub 2015 Jul 9.

15.

Localised mitogenic activity in horses following infection with Streptococcus equi.

McLean R, Rash NL, Robinson C, Waller AS, Paillot R.

Res Vet Sci. 2015 Jun;100:100-4. doi: 10.1016/j.rvsc.2015.03.015. Epub 2015 Mar 11.

PMID:
25841794
16.

[Postvaccinal fatal Streptococcus zooepidemicus necrotizing fasciitis in a young dog: a case report].

Greijdanus-Van Der Putten SW, Vos JH, Duvekot JR, Paillot R, McLean R, Brokers HJ, Heuvelink AE, Meertens NM, Waller AS.

Tijdschr Diergeneeskd. 2014 Sep 1;139(9):24-7. Dutch.

PMID:
25272902
17.

Prevalence and disease associations of superantigens szeF, szeN and szeP in the S. zooepidemicus population and possible functional redundancy of szeF.

Rash NL, Robinson C, DeSouza N, Nair S, Hodgson H, Steward K, Waller AS, Paillot R.

Res Vet Sci. 2014 Dec;97(3):481-7. doi: 10.1016/j.rvsc.2014.09.001. Epub 2014 Sep 16.

PMID:
25267286
18.

Report of the International Equine Influenza Roundtable Expert Meeting at Le Touquet, Normandy, February 2013.

Slater J, Borchers K, Chambers T, Cullinane A, Duggan V, Elton D, Legrand L, Paillot R, Fortier G.

Equine Vet J. 2014 Nov;46(6):645-50. doi: 10.1111/evj.12302. Epub 2014 Aug 21. No abstract available.

PMID:
25146166
19.

Equine mesenchymal stromal cells and embryo-derived stem cells are immune privileged in vitro.

Paterson YZ, Rash N, Garvican ER, Paillot R, Guest DJ.

Stem Cell Res Ther. 2014 Jul 30;5(4):90. doi: 10.1186/scrt479.

20.

A Systematic Review of Recent Advances in Equine Influenza Vaccination.

Paillot R.

Vaccines (Basel). 2014 Nov 14;2(4):797-831. doi: 10.3390/vaccines2040797. Review.

21.

Outbreak of upper respiratory disease in horses caused by Streptococcus equi subsp. zooepidemicus ST-24.

Lindahl SB, Aspán A, Båverud V, Paillot R, Pringle J, Rash NL, Söderlund R, Waller AS.

Vet Microbiol. 2013 Sep 27;166(1-2):281-5. doi: 10.1016/j.vetmic.2013.05.006. Epub 2013 May 25.

PMID:
23773239
22.

Duration of equine influenza virus shedding and infectivity in immunised horses after experimental infection with EIV A/eq2/Richmond/1/07.

Paillot R, Prowse L, Montesso F, Stewart B, Jordon L, Newton JR, Gilkerson JR.

Vet Microbiol. 2013 Sep 27;166(1-2):22-34. doi: 10.1016/j.vetmic.2013.04.027. Epub 2013 May 9.

PMID:
23769636
23.

A systematic review of the immune-modulators Parapoxvirus ovis and Propionibacterium acnes for the prevention of respiratory disease and other infections in the horse.

Paillot R.

Vet Immunol Immunopathol. 2013 May 15;153(1-2):1-9. doi: 10.1016/j.vetimm.2013.01.010. Epub 2013 Feb 5. Review.

PMID:
23481655
24.

Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.

Paillot R, Prowse L, Montesso F, Huang CM, Barnes H, Escala J.

Vet Microbiol. 2013 Mar 23;162(2-4):396-407. doi: 10.1016/j.vetmic.2012.10.019. Epub 2012 Oct 24.

PMID:
23146168
25.

ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse.

Paillot R, Prowse L.

Vet Immunol Immunopathol. 2012 Jan 15;145(1-2):516-21. doi: 10.1016/j.vetimm.2011.11.019. Epub 2011 Nov 26.

PMID:
22178272
26.

Streptococcus equi: a pathogen restricted to one host.

Waller AS, Paillot R, Timoney JF.

J Med Microbiol. 2011 Sep;60(Pt 9):1231-40. doi: 10.1099/jmm.0.028233-0. Epub 2011 Jul 14. Review.

PMID:
21757503
27.

Characterization of pneumonia due to Streptococcus equi subsp. zooepidemicus in dogs.

Priestnall SL, Erles K, Brooks HW, Cardwell JM, Waller AS, Paillot R, Robinson C, Darby AC, Holden MT, Schöniger S.

Clin Vaccine Immunol. 2010 Nov;17(11):1790-6. doi: 10.1128/CVI.00188-10. Epub 2010 Sep 22.

28.

Identification of three novel superantigen-encoding genes in Streptococcus equi subsp. zooepidemicus, szeF, szeN, and szeP.

Paillot R, Darby AC, Robinson C, Wright NL, Steward KF, Anderson E, Webb K, Holden MT, Efstratiou A, Broughton K, Jolley KA, Priestnall SL, Marotti Campi MC, Hughes MA, Radford A, Erles K, Waller AS.

Infect Immun. 2010 Nov;78(11):4817-27. doi: 10.1128/IAI.00751-10. Epub 2010 Aug 16.

29.

Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.

Paillot R, Prowse L, Donald C, Medcalf E, Montesso F, Bryant N, Watson J, Jeggo M, Elton D, Newton R, Trail P, Barnes H.

Vet Immunol Immunopathol. 2010 Aug 15;136(3-4):272-83. doi: 10.1016/j.vetimm.2010.03.019. Epub 2010 Mar 27.

PMID:
20400185
30.

Contribution of each of four Superantigens to Streptococcus equi-induced mitogenicity, gamma interferon synthesis, and immunity.

Paillot R, Robinson C, Steward K, Wright N, Jourdan T, Butcher N, Heather Z, Waller AS.

Infect Immun. 2010 Apr;78(4):1728-39. doi: 10.1128/IAI.01079-09. Epub 2010 Feb 1.

31.

Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak.

Bryant NA, Paillot R, Rash AS, Medcalf E, Montesso F, Ross J, Watson J, Jeggo M, Lewis NS, Newton JR, Elton DM.

Vet Res. 2010 Mar-Apr;41(2):19. doi: 10.1051/vetres/2009067. Epub 2009 Oct 29.

32.

Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007.

Bryant NA, Rash AS, Russell CA, Ross J, Cooke A, Bowman S, MacRae S, Lewis NS, Paillot R, Zanoni R, Meier H, Griffiths LA, Daly JM, Tiwari A, Chambers TM, Newton JR, Elton DM.

Vet Microbiol. 2009 Jul 2;138(1-2):41-52. doi: 10.1016/j.vetmic.2009.03.004. Epub 2009 Mar 13.

PMID:
19346084
33.

Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens.

Holden MT, Heather Z, Paillot R, Steward KF, Webb K, Ainslie F, Jourdan T, Bason NC, Holroyd NE, Mungall K, Quail MA, Sanders M, Simmonds M, Willey D, Brooks K, Aanensen DM, Spratt BG, Jolley KA, Maiden MC, Kehoe M, Chanter N, Bentley SD, Robinson C, Maskell DJ, Parkhill J, Waller AS.

PLoS Pathog. 2009 Mar;5(3):e1000346. doi: 10.1371/journal.ppat.1000346. Epub 2009 Mar 27.

34.

Equine herpesvirus myeloencephalopathy: unravelling the enigma.

Nugent J, Paillot R.

Vet J. 2009 Jun;180(3):271-2. doi: 10.1016/j.tvjl.2008.12.002. Epub 2009 Jan 13. No abstract available.

PMID:
19141371
35.

Australian equine influenza: vaccine protection in the UK.

Bryant N, Rash A, Lewis N, Elton D, Montesso F, Ross J, Newton R, Paillot R, Watson J, Jeggo M.

Vet Rec. 2008 Apr 12;162(15):491-2. No abstract available.

PMID:
18408203
36.

Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.

Paillot R, Grimmett H, Elton D, Daly JM.

Vet Res. 2008 May-Jun;39(3):21. doi: 10.1051/vetres:2007062. Epub 2008 Feb 7.

37.

Clinical, immunophenotypic and functional characterisation of T-cell leukaemia in six horses.

Rendle DI, Durham AE, Thompson JC, Archer J, Mitchell M, Saunders K, Millere J, Paillot R, Smith KC, Kydd JH.

Equine Vet J. 2007 Nov;39(6):522-8.

PMID:
18065310
38.

New assays to measure equine influenza virus-specific Type 1 immunity in horses.

Paillot R, Kydd JH, MacRae S, Minke JM, Hannant D, Daly JM.

Vaccine. 2007 Oct 16;25(42):7385-98. Epub 2007 Sep 4.

PMID:
17881098
39.

Equine herpesvirus-1-specific interferon gamma (IFNgamma) synthesis by peripheral blood mononuclear cells in thoroughbred horses.

Luce R, Shepherd M, Paillot R, Blacklawst B, Wood JL, Kydd JH.

Equine Vet J. 2007 May;39(3):202-9.

PMID:
17520969
40.

Frequency and phenotype of EHV-1 specific, IFN-gamma synthesising lymphocytes in ponies: the effects of age, pregnancy and infection.

Paillot R, Daly JM, Luce R, Montesso F, Davis-Poynter N, Hannant D, Kydd JH.

Dev Comp Immunol. 2007;31(2):202-14. Epub 2006 Jun 21.

PMID:
16824599
41.

Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.

Paillot R, Kydd JH, Sindle T, Hannant D, Edlund Toulemonde C, Audonnet JC, Minke JM, Daly JM.

Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):225-33. Epub 2006 Apr 18.

PMID:
16621023
42.

Vaccination against equine influenza: quid novi?

Paillot R, Hannant D, Kydd JH, Daly JM.

Vaccine. 2006 May 8;24(19):4047-61. Epub 2006 Feb 28. Review.

PMID:
16545507
43.

Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.

Paillot R, Ellis SA, Daly JM, Audonnet JC, Minke JM, Davis-Poynter N, Hannant D, Kydd JH.

Vaccine. 2006 Mar 6;24(10):1490-500. Epub 2005 Oct 21.

PMID:
16269205
44.

Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1.

Paillot R, Daly JM, Juillard V, Minke JM, Hannant D, Kydd JH.

Vaccine. 2005 Aug 22;23(36):4541-51.

PMID:
15913852
45.

Toward a detailed characterization of feline immunodeficiency virus-specific T cell immune responses and mediated immune disorders.

Paillot R, Richard S, Bloas F, Piras F, Poulet H, Brunet S, Andreoni C, Juillard V.

Vet Immunol Immunopathol. 2005 Jun 15;106(1-2):1-14.

PMID:
15910988
46.

Quantitative analysis of the antigen-specific IFNgamma+ T cell-mediated immune response in conventional outbred pigs: kinetics and duration of the DNA-induced IFNgamma+ CD8+ T cell response.

Laval F, Paillot R, Bollard S, Fischer L, Audonnet JC, Andreoni C, Juillard V.

Vet Immunol Immunopathol. 2002 Dec;90(3-4):191-201.

PMID:
12459166
47.

Functional and phenotypic characterization of distinct porcine dendritic cells derived from peripheral blood monocytes.

Paillot R, Laval F, Audonnet JC, Andreoni C, Juillard V.

Immunology. 2001 Apr;102(4):396-404.

48.

Mechanisms of action of methotrexate.

Genestier L, Paillot R, Quemeneur L, Izeradjene K, Revillard JP.

Immunopharmacology. 2000 May;47(2-3):247-57. Review. No abstract available.

PMID:
10878292
49.

Activation-dependent lymphocyte apoptosis induced by methotrexate.

Paillot R, Genestier L, Fournel S, Ferraro C, Miossec P, Revillard JP.

Transplant Proc. 1998 Aug;30(5):2348-50. No abstract available.

PMID:
9723499
50.

Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.

Genestier L, Paillot R, Fournel S, Ferraro C, Miossec P, Revillard JP.

J Clin Invest. 1998 Jul 15;102(2):322-8.

Supplemental Content

Loading ...
Support Center